ValuationViz

MIRM fund manager activity

Mirum Pharmaceuticals, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q1 2025 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed82,476$9,655,4640.00%Aug 4, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed2,385$279,2120.00%Aug 14, 2026
Polen Capital ManagementAdded20,899$2,446,6460.02%Aug 4, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementAdded93,109$8,601,4090.00%May 5, 2026
Joel Greenblatt - Gotham Asset ManagementNew3,144$290,4430.00%May 15, 2026
Polen Capital ManagementAdded20,531$1,896,6540.01%May 14, 2026

Older quarters